Translational Medicine Asso. Manager
職位描述
Translational Medicine supports programs in all phases of development and focuses on making measurements on human samples to understand why, and identify which, patients benefit from particular treatments, what doses and schedules of treatments to use and the mechanisms underlying the development of resistance to treatment.In early oncology studies Translational medicine are responsible for the biomarker strategy and implementation which includes all exploratory analyses of clinical trial samples and prospective testing for trial recruitment where required.The role holder will work closely with the Translational Medicine Lead and diagnostic vendors to develop options for biomarker testing. The role holder will also work closely with the clinical study team to implement the selected options, monitoring ongoing activities to ensure quality of data output.The role holder is accountable for ensuring that all activities are delivered demonstrating behaviors and values aligned to AstraZeneca Code of Conduct and supporting policies, standards and procedures, including compliant management of budget, safety, health and environment. Typical Accountabilities * Support the delivery and execution of the biomarker plan for clinical studies, ensuring that is based on translational strategy led by translational medicine leader working closely with the clinical team and other supporting functions. * Manage external alliance, support China TM activities including assay transfer, vendor evaluation and collaborations; Work effectively with procurement to contract the biomarker operations to deliver fit-for purpose laboratory testing from sample receipt to delivery of results, compliant with clinical sample testing guidelines where necessary. * Ensure biomarker plan commits CROs/laboratories to deliver clinical testing; Lead the creation and maintenance of study documents such as communication, quality management and issue escalation plans * Ensure HGR compliance by supporting HGR application, tracking study-related approvals, assure compliance of on-going and legacy studies, sample management. * Review and approve sample instructions for clinical sites when necessary; Monitor biomarker data quality and timeliness via agreed QC plan; Be accountable for the time, cost and quality of agreed deliverables. * Monitor and ensure compliance with all AstraZeneca Policies and Standards, HGR regulations and China biosafetey laws, and address instances of non-compliance. Education, Qualifications, Skills and ExperienceEssential * Bachelor's degree required, with at least 7 years of relevant experience in the biopharmaceutical industry * Demonstrable experience of analytical diagnostic assay validation and use in a clinical testing setting. * Knowledge of clinical testing procedures and applicable laboratory testing regulations such as Good Clinical Practice, CAP/CLIA, Good Clinical Practice and Quality Systems Regulation) * Experience of working with testing partners to drive timely and successful outcomes, through effectively working across internal and external boundaries. * Ability to communicate with stakeholders for study updates, testing progress through oral presentations and progress reports * Ability to identify risks and escalate appropriatelySkills & Capabilities * Good interpersonal skills and ability to act as an ambassador for TM/AZ internally and externally * Ability to effectively communicate and interact successfully with multiple customers across functional boundaries * A confident team player who is assertive but willing to listen and learn from the views of others * Excellent organisational skills, with the proven ability to deliver high quality work under pressure and against tight timelinesDesirable * Masters / PhD or equivalent experience in a relevant subject * An understanding of drug and companion diagnostic assay co-development and experience working in early and late phase projects . * Understanding of related areas e.g. segmentation tool discovery, drug-diagnostic co-development. * Understandings for Human Genetic Resource regulations and previous experiences in application, amendment and submission processes.【AstraZeneca is an equal opportunity employer. AstraZeneca will consider all qualified applicants for employment without discrimination on grounds of disability, sex or sexual orientation, pregnancy or maternity leave status, race or national or ethnic origin, age, religion or belief, gender identity or re-assignment, marital or civil partnership status, protected veteran status (if applicable) or any other characteristic protected by law. AstraZeneca only employs individuals with the right to work in the country/ies where the role is advertised. 阿斯利康是一家提供平等機(jī)會的企業(yè),我們將考慮所有符合條件的求職者就業(yè)。不因殘疾、性別或性取向、懷孕或產(chǎn)假狀況、種族或民族或族裔出身、年齡、宗教或信仰、性別認(rèn)同或變更、婚姻或伴侶關(guān)系、受保護(hù)的退伍軍人身份(如果適用)及任何其他受法律保護(hù)的特征而產(chǎn)生歧視。】
企業(yè)簡介
阿斯利康是全球領(lǐng)先制藥公司,由前瑞典阿斯特拉公司和前英國捷利康公司于1999年合并而成。阿斯利康在6大治療領(lǐng)域為患者提供富于創(chuàng)新,卓有成效的醫(yī)藥產(chǎn)品,包括消化、心血管、腫瘤、中樞神經(jīng)、麻醉和呼吸等,其中許多產(chǎn)品居于世界領(lǐng)先地位。
阿斯利康總部位于英國倫敦,研發(fā)總部位于瑞典。產(chǎn)品銷售覆蓋全球100多個國家和地區(qū)。2005年公司銷售收入為240億美元。
阿斯利康擁有強(qiáng)大的研發(fā)能力,平均每個工作日的研發(fā)投入達(dá)到1400萬美元 (2005年研發(fā)總投入為34億美元)。我們在7個國家設(shè)有11個研發(fā)機(jī)構(gòu),共有11,900名員工從事與新藥研發(fā)相關(guān)的工作。
阿斯利康擁有極具希望的早期開發(fā)產(chǎn)品組合,共有45個項目處于臨床前研究階段、17個項目處于一期臨床研究階段、13個項目處于二期臨床研究階段、6個項目處于三期臨床研究階段。
阿斯利康在全球19個國家有27個生產(chǎn)基地,共有14,000名員工致力于為客戶提供安全、有效、高質(zhì)量的產(chǎn)品。
阿斯利康在全球共有65,000名員工,從事醫(yī)藥產(chǎn)品和醫(yī)療服務(wù)的研發(fā)、生產(chǎn)和銷售業(yè)務(wù)。
阿斯利康被列入道瓊斯可持續(xù)發(fā)展指數(shù)(全球)以及顯示企業(yè)良好社會責(zé)任度的富時社會責(zé)任指數(shù)(FTSE4Good Index)。
職位發(fā)布企業(yè)
阿斯利康制藥公司
企業(yè)性質(zhì):
企業(yè)規(guī)模:1-49人
成立年份:
企業(yè)網(wǎng)址:http://www.dyyiqinggongmao.cn
企業(yè)地址:海淀區(qū)
該企業(yè)其他職位更多>>
相關(guān)職位推薦
上海相關(guān)職位: 耗材市場經(jīng)理 市場經(jīng)理(耗材) 銷售主管
熱門區(qū)域招聘: 重慶 北京 上海 浙江 江蘇 廣東 山東 湖南 安徽 河北
上海招聘企業(yè): 百進(jìn)冠合(海南) 醫(yī)療科技有限公司 上海華茂藥業(yè)有限公司 上海信誼藥廠有限公司 上海強(qiáng)生制藥 歐姆龍健康醫(yī)療(中國)有限公司 青海瑞成藥業(yè)(集團(tuán))有限公司 上海交通大學(xué)醫(yī)學(xué)院附屬瑞金醫(yī)院 復(fù)旦大學(xué)附屬中山醫(yī)院 上海復(fù)星醫(yī)藥 上海醫(yī)藥集團(tuán)
職位發(fā)布日期: 2023-05-18